About Us

Our Partners & Investors

Boston Scientific and Functional Neuromodulation entered into a strategic investment partnership in 2016 to further develop DBS of the fornix for mild Alzheimer's disease patients.


Functional Neuromodulation recently closed a $10.4 million round of financing with Genesys Capital, one of the largest Canadian-based venture capital firms exclusively focused on the life sciences industry.


Medtronic, Inc. provided capital investment and the company's DBS systems for use in Functional Neuromodulation's ADvance Study.


CAUTION — Investigational device. Limited by Federal law to investigational use.

Functional Neuromodulation, Ltd. | 2 Oliver St., Suite 616 | Boston, MA 02109 | info@fxneuromod.com | 1-866-296-4040
© 2018 Functional Neuromodulation Ltd. All rights reserved.